- Home
- ONCY vs EEA Comparison
ONCY vs EEA Comparison
Compare ONCY & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- EEA
- Stock Information
- Founded
- ONCY 1998
- EEA 1986
- Country
- ONCY Canada
- EEA Germany
- Employees
- ONCY N/A
- EEA N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- EEA Trusts Except Educational Religious and Charitable
- Sector
- ONCY Health Care
- EEA Finance
- Exchange
- ONCY Nasdaq
- EEA Nasdaq
- Market Cap
- ONCY 56.2M
- EEA 57.7M
- IPO Year
- ONCY 1999
- EEA N/A
- Fundamental
- Price
- ONCY $0.73
- EEA $8.99
- Analyst Decision
- ONCY Strong Buy
- EEA
- Analyst Count
- ONCY 2
- EEA 0
- Target Price
- ONCY $4.00
- EEA N/A
- AVG Volume (30 Days)
- ONCY 563.2K
- EEA 9.2K
- Earning Date
- ONCY 03-06-2025
- EEA 01-01-0001
- Dividend Yield
- ONCY N/A
- EEA 1.92%
- EPS Growth
- ONCY N/A
- EEA N/A
- EPS
- ONCY N/A
- EEA N/A
- Revenue
- ONCY N/A
- EEA N/A
- Revenue This Year
- ONCY N/A
- EEA N/A
- Revenue Next Year
- ONCY N/A
- EEA N/A
- P/E Ratio
- ONCY N/A
- EEA N/A
- Revenue Growth
- ONCY N/A
- EEA N/A
- 52 Week Low
- ONCY $0.67
- EEA $7.45
- 52 Week High
- ONCY $1.53
- EEA $9.26
- Technical
- Relative Strength Index (RSI)
- ONCY 40.10
- EEA 64.38
- Support Level
- ONCY $0.71
- EEA $8.97
- Resistance Level
- ONCY $0.79
- EEA $9.15
- Average True Range (ATR)
- ONCY 0.04
- EEA 0.11
- MACD
- ONCY 0.00
- EEA 0.02
- Stochastic Oscillator
- ONCY 32.71
- EEA 71.93
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.